Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women

J Obstet Gynaecol. 2015;35(8):835-8. doi: 10.3109/01443615.2015.1014326. Epub 2015 May 13.

Abstract

In post-menopausal period vulvo-vaginal atrophy (VVA)-related symptoms may seriously affect women's quality of life. Hormonal replacement therapy effectively relieves these symptoms but it is not always safe or accepted, and a non-hormonal treatment is often needed instead. Over a period of 12 weeks, we tested the effect of a twice-a-week vulvo-vaginal application of a hyaluronic acid, AC collagen, isoflavones and vitamins-based cream (Perilei Pausa) on 35 women in post-menopausal period, reporting VVA-related symptoms. After 12 weeks of treatment with Perilei Pausa a significant improvement in vaginal dryness, vulvo-vaginal itching, dyspareunia (P < 0.001), dysuria (P = 0.02), nocturia (P = 0.009) and pollakiuria (P = 0.005) was reported by the women. Colposcopical score assessing the intensity of atrophic colpitis, cervico-vaginal paleness and petechiae was also reduced (P = 0.037, P = 0.016 and P = 0.032, respectively). No significant difference in terms of maturation value of cervico-vaginal epithelium was observed. In conclusion, Perilei Pausa may represent an effective and safe alternative treatment of symptomatic VVA in post-menopausal women.

Keywords: collagen; dyspareunia; hyaluronic acid; isoflavones; vulvo-vaginal atrophy.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Atrophy / drug therapy
  • Colposcopy
  • Epithelium / drug effects
  • Female
  • Humans
  • Middle Aged
  • Postmenopause*
  • Vagina / drug effects*
  • Vagina / pathology
  • Vaginal Creams, Foams, and Jellies / pharmacology
  • Vaginal Creams, Foams, and Jellies / therapeutic use*
  • Vaginal Diseases / drug therapy*
  • Vulvar Diseases / drug therapy*

Substances

  • Vaginal Creams, Foams, and Jellies